SIA Submits Letter to FDA Addressing Thermographic Systems
SIA recently submitted a letter to the Food and Drug Administration (FDA) commissioner Stephen Hahn with a focus on an awareness that some companies are not following FDA guidelines related to the use of thermal imaging systems during the COVID-19 pandemic. The letter also encouraged the enforcement of FDA’s guidelines.
According to SIA, the organization received reports from member companies and had dialogue with those members who shared with additional information, and it became clear this was an issue, which was further reinforced by SIA’s thermal camera ad hoc working group discussions on this issue.